Catastrophic antiphospholipid syndrome;Le syndrome catastrophique des antiphospholipides

Revue de Medecine Interne

Volumn 33, Issue 4, 2012, Pages 194-199

  Costedoat Chalumeau, N ^a   Arnaud, L ^a   Saadoun, D ^a   Chastre, J ^a   Leroux, G ^a   Cacoub, P ^a   Amoura, Z ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

ANTICOAGULANT AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; BRAIN DISEASE; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GASTROINTESTINAL DISEASE; HEART DISEASE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPERTENSION; IMMUNOPROPHYLAXIS; KIDNEY FAILURE; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT EDUCATION; PERIOPERATIVE PERIOD; PLASMAPHERESIS; RESPIRATORY DISTRESS SYNDROME; SHORT SURVEY; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BIOLOGICAL MARKERS; CATASTROPHIC ILLNESS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE ORGAN FAILURE; PLASMA EXCHANGE; RENAL INSUFFICIENCY; RESPIRATORY INSUFFICIENCY; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84858749759     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2012.01.005     Document Type: Short Survey

References (34)

1. Asherson R.A. The catastrophic antiphospholipid syndrome. J Rheumatol 1992, 19:508-512.
2. Asherson R.A., Cervera R., Piette J.C., Font J., Lie J.T., Burcoglu A., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998, 77:195-207.
3. Bucciarelli S., Cervera R., Espinosa G., Gomez-Puerta J.A., Ramos-Casals M., Font J. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmun Rev 2006, 6:72-75.
4. Cervera R., Bucciarelli S., Plasin M.A., Gomez-Puerta J.A., Plaza J., Pons-Estel G., et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the " CAPS Registry" J Autoimmun 2009, 32:240-245.
5. Cervera R., Font J., Gomez-Puerta J.A., Espinosa G., Cucho M., Bucciarelli S., et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005, 64:1205-1209.
6. Asherson R.A., Espinosa G., Menahem S., Yinh J., Bucciarelli S., Bosch X., et al. Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum 2008, 37:366-372.
7. Asherson R.A., Cervera R., de Groot P.G., Erkan D., Boffa M.C., Piette J.C., et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003, 12:530-534.
8. Erkan D., Espinosa G., Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 2010, 10:74-79.
9. Amoura Z., Costedoat-Chalumeau N., Veyradier A., Wolf M., Ghillani-Dalbin P., Cacoub P., et al. Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome. Arthritis Rheum 2004, 50:3260-3264.
10. Pauzner R., Greinacher A., Selleng K., Althaus K., Shenkman B., Seligsohn U. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Thromb Haemost 2009, 7:1070-1074.
11. Pasquali J.L., Sibilia J., Poindron V., Korganow A.S., Soulas-Sprauel P., Martin T. Aspects immunologiques du syndrome des antiphospholipides. Rev Med Interne 2011, 10.1016/j.revmed.2011.08.008.
12. Ortega-Hernandez O.D., Agmon-Levin N., Blank M., Asherson R.A., Shoenfeld Y. The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. J Autoimmun 2009, 32:1-6.
13. Shoenfeld Y., Blank M., Cervera R., Font J., Raschi E., Meroni P.L. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 2006, 65:2-6.
14. Sene D., Piette J.C., Cacoub P. Anticorps antiphospholipide, syndrome des anticorps antiphospholipides et infections virales. Rev Med Interne 2009, 30:135-141.
15. Espinosa G., Cervera R., Asherson R.A. Catastrophic antiphospholipid syndrome and sepsis. A common link?. J Rheumatol 2007, 34:923-926.
16. Cervera R., Group C.R.P. Catastrophic antiphospholipid syndrome (CAPS): update from the " CAPS Registry" Lupus 2010, 19:412-418.
17. Lacueva J., Enriquez R., Cabezuelo J.B., Arenas M.D., Teruel A., Gonzalez C. Acute renal failure as first clinical manifestation of the primary antiphospholipid syndrome. Nephron 1993, 64:479-480.
18. Nochy D., Daugas E., Droz D., Beaufils H., Grunfeld J.P., Piette J.C., et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999, 10:507-518.
19. Bucciarelli S., Espinosa G., Asherson R.A., Cervera R., Claver G., Gomez-Puerta J.A., et al. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2006, 65:81-86.
20. Leroux G., Sellam J., Costedoat-Chalumeau N., Le Thi Huong D., Combes A., Tieulie N., et al. Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008, 17:139-147.
21. Frances C., Niang S., Laffitte E., Pelletier F., Costedoat N., Piette J.C. Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases. Arthritis Rheum 2005, 52:1785-1793.
22. Frances C., Barete S., Soria A. Manifestations dermatologiques du syndrome des antiphospholipides. Rev Med Interne 2011, 10.1016/j.revmed.2011.10.003.
23. Dessailloud R., Papo T., Vaneecloo S., Gamblin C., Vanhille P., Piette J.C. Acalculous ischemic gallbladder necrosis in the catastrophic antiphospholipid syndrome. Arthritis Rheum 1998, 41:1318-1320.
24. Papo T., Le Thi Huong D., Godeau P., Piette J.C. Pancréatites et maladies systémiques. Gastroenterol Clin Biol 1997, 768-775.
25. Espinosa G., Santos E., Cervera R., Piette J.C., de la Red G., Gil V., et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore) 2003, 82:106-118.
26. Josse S., Benhamou Y., Girault C., Lecam-Duchez V., Provost D., Verspyck E., et al. Plaquettes-blues du post-partum. Rev Med Interne 2011, 32:255-262.
27. Cervera R. Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome. Curr Rheumatol Rep 2010, 12:70-76.
28. Bayraktar U.D., Erkan D., Bucciarelli S., Espinosa G., Asherson R. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol 2007, 34:346-352.
29. Erkan D., Asherson R.A., Espinosa G., Cervera R., Font J., Piette J.C., et al. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 2003, 62:530-533.
30. Iglesias-Jimenez E., Camacho-Lovillo M., Falcon-Neyra D., Lirola-Cruz J., Neth O. Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab. Pediatrics 2010, 125:e1523-e1528.
31. Espinosa G., Berman H., Cervera R. Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmun Rev 2011, 10:664-668.
32. Lonze B.E., Singer A.L., Montgomery R.A. Eculizumab and renal transplantation in a patient with CAPS. N Engl J Med 2010, 362:1744-1745.
33. Repesse X., Freund Y., Mathian A., Hervier B., Amoura Z., Luyt C.E. Successful extracorporeal membrane oxygenation for refractory cardiogenic shock due to the catastrophic antiphospholipid syndrome. Ann Intern Med 2010, 153:487-488.
34. Erkan D., Leibowitz E., Berman J., Lockshin M.D. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002, 29:843-849.